Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/09/2000WO2000034455A3 Methods and systems useful for transferring genes into pancreatic islets ex vivo and into the pancreas in vivo
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032749A3 Methods and articles for regenerating living tissue
11/09/2000WO2000031238A3 Methods and reagents for increasing proliferative capacity and preventing replicative senescence
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000WO2000029439A9 The cxc chemokine h174 and methods for preventing damage to the nervous system
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000WO2000028813A9 Treatment of myelogenous leukemia
11/09/2000WO2000028034A3 Cytokine signal regulators
11/09/2000WO2000028033A3 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
11/09/2000WO2000028026A3 Gene expression modulated by opiate administration and withdrawal
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000026367A3 Therapeutics and diagnostics for ocular abnormalities
11/09/2000WO2000026244A3 A novel tumor necrosis factor family member, drl, and related compositions and methods
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
11/09/2000WO2000024768A3 Genes integrating signal transduction pathways
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000024254A9 Compositions and methods for modulating expression within smooth muscle cells
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000021509A3 Methods of treatment
11/09/2000WO2000020638A3 Methods and compositions for the diagnosis and therapy of prostate cancer
11/09/2000WO2000015826A3 Leptin induced genes
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000014112A3 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO1999058671A3 Human and nematode homologues of the yeast longevity assurance gene lag1
11/09/2000WO1999056769A3 Inhibition of helicobacter pylori proliferation
11/09/2000WO1999055868A3 Fizz proteins
11/09/2000WO1999047678A9 Interferon alpha plasmids and delivery systems, and methods of making and using the same
11/09/2000DE19922444A1 Verfahren zur Behandlung von TNF-Rezeptor vermittelten Krankheiten A method for the treatment of TNF-receptor-mediated diseases
11/09/2000DE19921027A1 Verbindungen mit antibiotischer Wirkung Compounds with antibiotic activity
11/09/2000DE19920816A1 Cephaibole, neue Antiparasitika aus Acremonium tubakii, Verfahren zu ihrer Herstellung und Verwendung derselben Cephaibols new antiparasitic drugs from Acremonium tubakii, processes for their preparation and use thereof
11/09/2000CA2407714A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000CA2373045A1 Gene therapy using tgf-.beta.
11/09/2000CA2372947A1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372907A1 Zymogen activation system
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372790A1 Monthly doses for treatment of streptococcus pneumonia infections
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372559A1 Neurite outgrowth and guidance by tenascin-c
11/09/2000CA2372279A1 Compositions containing benzimidazolones and progestogens
11/09/2000CA2372235A1 Conserved neisserial antigens
11/09/2000CA2372214A1 Modified exendins and exendin agonists
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000CA2372187A1 Ras oncogen p21 peptide vaccines
11/09/2000CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000CA2371702A1 Meg-3 protein
11/09/2000CA2371695A1 Morphogen-induced enhancement of fertility
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2371215A1 New compounds
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370587A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000CA2370504A1 Biochemical methods that eliminate corneal scars, opacification and haze
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2370252A1 Cancer treatment with endothelin receptor antagonists
11/09/2000CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000CA2369747A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2365900A1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000CA2365776A1 Method for treating abnormal cell proliferation in the brain
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2338799A1 Protein c derivatives
11/09/2000CA2336296A1 Novel peptide y-2
11/09/2000CA2335966A1 Method for inducing growth and enhancing survival of nervous tissue
11/08/2000EP1050758A1 Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
11/08/2000EP1050757A1 Methods of diagnosing or treating Alzheimer's disease on basis of increased cerebrospinal fluid levels of nerve growth factor
11/08/2000EP1050583A1 Hiv infection inhibitors
11/08/2000EP1050540A2 Inhibitors of dipeptidyl-aminopeptidase type IV
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1050306A1 CYTOKINE INDUCERS COMPRISING M161Ag
11/08/2000EP1049810A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
11/08/2000EP1049799A1 Antimicrobial compounds
11/08/2000EP1049795A1 Mmsc1 - an mmac1 interacting protein
11/08/2000EP1049787A1 Multipurpose antibody derivatives
11/08/2000EP1049782A1 Mutants of il-16, processes for their production, and their use
11/08/2000EP1049781A1 Human chemokine and its use for detection and treatment of breast disease
11/08/2000EP1049779A2 Lh-receptor gene promoter for tissue-specific gene expression
11/08/2000EP1049778A2 Recombinant proteins derived from hgf and msp
11/08/2000EP1049777A1 Acpl dna and polypeptides
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049775A1 Human btrcp protein
11/08/2000EP1049774A2 Promoter regions of the mouse and human telomerase rna component genes
11/08/2000EP1049773A1 Inhibition of cytokine production
11/08/2000EP1049772A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049769A2 Mutant herpes simplex viruses and uses thereof
1 ... 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 ... 3163